News | May 02, 2026
Bayer pushes stroke prevention drug forward in China as regulators accept key filing
Stroke is the second-leading cause of death and the third-leading cause of disability worldwide
Stroke is the second-leading cause of death and the third-leading cause of disability worldwide
While Drugs for Neglected Diseases initiative (DNDi) drives the R&D for neglected diseases, we collaborate with pharmaceutical companies at multiple stages, including sourcing promising molecules
Reshaped by COVID-19, rising test demand, and a shift toward decentralized diagnostics, qPCR has evolved from niche academic use to a core clinical engine
The trials -- ELOWEN-1 and ELOWEN-2 -- are designed to evaluate the drug in people living with lupus who experience active skin manifestations
With the convergence of AI, robotics, and neuroscience, Motorica is advancing toward more intuitive, intent-driven prosthetic systems
The twin designations are designed to speed up the development and review of promising medicines targeting serious conditions with high unmet need
Health innovations are viewed more positively than food and agricultural technologies
CPHI India from 23–25 November 2026 at Yashobhoomi (India International Convention and Expo Centre), while PMEC India from 24–26 November 2026 at India Expo Mart
New medical and wellness centre combines on-site care with telehealth to support industrial workforce and surrounding communities
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
